Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• Respiratory syncytial virus (RSV) is a major global cause of lower respiratory tract infections (LRTIs), particularly impacting infants, the elderly, and immunocompromised individuals.
• RSV infections peak during winter, leading to millions of cases annually and posing a significant public health challenge.
• Current limitations in effective vaccines and antiviral treatments underscore the urgent need for advanced research and control strategies.

Purpose of the Study:

• To provide a comprehensive review of Respiratory Syncytial Virus (RSV).
• To cover RSV's biological characteristics, epidemiology, clinical features, diagnosis, and treatment.
• To explore prevention strategies and future research directions for RSV control.

Main Methods:

• Systematic literature review of existing research on RSV.
• Analysis of epidemiological data and clinical case studies.
• Synthesis of information on diagnostic tools, therapeutic interventions, and preventive measures.

Main Results:

• RSV is a leading cause of infant LRTIs, with significant global incidence.
• Progress has been made in understanding RSV's pathology, immune response, and long-term effects.
• Existing treatments are limited, and no effective vaccine is currently available.

Conclusions:

• A comprehensive understanding of RSV is crucial for developing effective public health strategies.
• Continued research into RSV pathogenesis, diagnostics, and therapeutics is essential.
• Advancements in technology offer new avenues for RSV prevention and control, requiring further exploration.